CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

BodyMedia

BodyMedia is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Pittsburgh, PA. To find more information about BodyMedia, please visit www.bodymedia.com

Nexeon MedSystems

Nexeon MedSystems is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Address

WRKOUT is the future of fitness - delivering premium personal training LIVE to any device. No recorded content. No expensive equipment.

BCI Healthcare

BCI Healthcare is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MyndVR

MyndVR is creating a new genre of entertaining and therapeutic experiences in Virtual Reality specifically designed for our dynamic and aging population living in Senior Living Communities and at Home.